seryl- leucyl- isoleucyl- glycyl- lysyl- valinamide
a proteinase-activated receptor agonist
Also Known As:
SLIGKV-NH2; Ser-Leu-Ile-Gly-Lys-Val-NH2
Networked: 2
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Mrozkova, Petra:
1 article
(01/2016)
|
2. | Palecek, Jiri:
1 article
(01/2016)
|
3. | Spicarova, Diana:
1 article
(01/2016)
|
4. | Chen, Li:
1 article
(11/2012)
|
5. | Chen, Xiaoyi:
1 article
(11/2012)
|
6. | Hai, Ou:
1 article
(11/2012)
|
7. | Li, Fei:
1 article
(11/2012)
|
8. | Li, Xuan:
1 article
(11/2012)
|
9. | Xie, Liqun:
1 article
(11/2012)
|
10. | Zhao, Junyan:
1 article
(11/2012)
|
Related Diseases
Related Drugs and Biologics